Erratum: Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants (Genetics in Medicine (2022) 24(1) (119–129), (S1098360021011308), (10.1016/j.gim.2021.08.016))

ENIGMA Consortium and CIMBA Consortium

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Genetics in Medicine 2022; https://doi.org/10.1016/j.gim.2021.08.016 In the article “Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants” by Li H et al (Genet Med 2022;24:119-129), the affiliations for authors Siranoush Manoukian and Barbara Pasini were not listed correctly. The affiliations have been corrected online and can be accessed at https://doi.org/10.1016/j.gim.2021.08.016.

Original languageEnglish (US)
Pages (from-to)2208
Number of pages1
JournalGenetics in Medicine
Volume24
Issue number10
DOIs
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Erratum: Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants (Genetics in Medicine (2022) 24(1) (119–129), (S1098360021011308), (10.1016/j.gim.2021.08.016))'. Together they form a unique fingerprint.

Cite this